Surveying the landscape from scientific discovery and technical innovation to late-stage clinical trials of drugs and diagnostics, DDN digs into the stories that are set to transform biomedical research and the business of human health.
Exploring drug discovery, development and diagnostics
Each month, we offer our readers the latest news to keep them up-to-date with their own and allied fields, as well as longer overviews of the state of a specific field or endeavor through our Special Reports and Focus Features. And in our commentaries and Q&A articles, the readers hear from the research and industry insiders themselves for keen insights.
-
34,000+
Total Qualified Print Circulation
-
40%
of Drug Discovery News' audience works in pharmaceutical research
-
50%
of Drug Discovery News' Audience work at commercial / industrial labs
-
80,000+
registrants for our e-newsletter offerings
"With a clear layout, people can quickly identify areas of interest to them in addition to the general news at the beginning of the publication. With the added benefit of being written in an accessible way to both CEOs and Scientists."
